: Medicare drug price negotiations move forward with all drugmakers participating, White House says 

Novo Nordisk is latest drugmaker to challenge negotiation program in court. 

Previous post The Ratings Game: Airbnb’s stock slumps after KeyBanc downgrade on expectations for a pullback in leisure travel
Next post Retirement Hacks: Medicare open enrollment: if you’re confused, this program can help